Need for Lifestyle Intervention: How to Begin
The American Journal of CardiologyPublished 24 June 2005
John P. Foreyt
Citations45
SJR quartileQ2
SJR score0.93
SNIP0.73
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Lifestyle change strategies--including setting reasonable goals, raising awareness, confronting barriers to change, managing stress, cognitive restructuring, preventing relapse, and providing support--are the keys to long-term success.
Abstract
The metabolic syndrome is the fastest growing disease entity in the world. Prevention and effective treatment emphasize lifestyle intervention, including healthful diet, physical activity, and pharmacologic agents to target specific risk factors. Weight loss improves all aspects of the metabolic syndrome and is a primary intervention target. Effective weight management also helps prevent the development of the metabolic syndrome. Lifestyle change strategies--including setting reasonable goals, raising awareness, confronting barriers to change, managing stress, cognitive restructuring, preventing relapse, and providing support--are the keys to long-term success.
Keywords
Medicine
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
JAMAExecutive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
25,992 Citations2001Evaluation Expert Panel on Detection
JAMAPrevalence of the Metabolic Syndrome Among US Adults
6,698 Citations2002Earl S. Ford, Wayne H. Giles +1 more
These results from a representative sample of US adults show that the metabolic syndrome is highly prevalent and the large numbers of US residents with the metabolic Syndrome may have important implications for the health care sector.
Changing for Good
645 Citations1994James O. Prochaska, John C. Norcross +1 more
Journal of Consulting and Clinical PsychologyWhat is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes.
459 Citations1997Gary D. Foster, Thomas A. Wadden +2 more
The dramatic disparity between patients' expectations and professional recommendations and the need to help patients accept more modest weight loss outcomes are illustrated.
General Hospital PsychiatryUse of the Beck depression inventory for primary care to screen for major depression disorders
317 Citations1999Robert A. Steer, Thomas A. Cavalieri +2 more
The Beck Depression Inventory for Primary Care (BDI-PC) was effective in screening for DSM-IV major depression disorders in outpatients who were scheduled for routine office visits with physicians specializing in internal medicine.
Behavior TherapySelf-monitoring may be necessary for successful weight control
309 Citations1993Raymond C. Baker, Daniel S. Kirschenbaum
The notions that self-monitoring, and perhaps “obsessive-compulsive self-regulation,” are necessary for successful weight control are supported.
European Journal of PharmacologyOrlistat: its current status as an anti-obesity drug
295 Citations2002Anne Ballinger, Steven Peikin
Over a 1-year period, obese patients taking orlistat in combination with a hypocaloric diet show a reduction of 2-5 kg over the weight decrease with placebo, and when continued for a second year in conjunction with a weight maintenance diet, orlistats reduces weight regain compared to placebo-treated patients.
PubMedSuccessful management of the obese patient.
64 Citations2000Walker S. C. Poston, John P. Foreyt
Behavior modification involves using such techniques as self-monitoring, stimulus control, cognitive restructuring, stress management and social support to systematically alter obesity-related behaviors.
Obesity ResearchWhat Is the Role of Cognitive‐Behavior Therapy in Patient Management?
62 Citations1998John P. Foreyt, Walker S. Carlos Poston
The role of cognitive-behavior therapy (CBT) in obesity treatment is summarized and new methods for delivering CBT interventions should be explored, including home-based programs and combination with adjunctive pharmacotherapy delivered in primary care centers.
Applied and Preventive PsychologyAttributes of successful approaches to weight loss and control
55 Citations1994John P. Foreyt, G. Ken Goodrick
Expert Opinion on PharmacotherapySibutramine and the management of obesity
37 Citations2004Walker S. Carlos Poston, John P. Foreyt
Sibutramine is a selective serotonin and noradrenaline re-uptake inhibitor approved for the long-term management of obesity that does have a consistent effect of increasing blood pressure and pulse.
Obesity ResearchLifestyle Treatments in Randomized Clinical Trials of Pharmacotherapies for Obesity
25 Citations2001Walker S. Carlos Poston, C. Keith Haddock +3 more
Balanced-deficit diets, low-calorie diets, and self-monitoring were the most used lifestyle treatments in published obesity studies and were incorporated into 40.7%, 25%, and 23.1% of pharmacotherapy studies, respectively.